Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels

BACKGROUND: Aldosterone is elevated in chronic kidney disease (CKD) and may be involved in hypertension. Surprisingly, the determinants of the plasma aldosterone concentration (PAC) and its role in hypertension are not well studied in CKD. Therefore, we studied the determinants of aldosterone and it...

Descripción completa

Detalles Bibliográficos
Autores principales: Gant, Christina M., Laverman, Gozewijn D., Vogt, Liffert, Slagman, Maartje C. J., Heerspink, Hiddo J. L., Waanders, Femke, Hemmelder, Marc H., Navis, Gerjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738866/
https://www.ncbi.nlm.nih.gov/pubmed/29262813
http://dx.doi.org/10.1186/s12882-017-0789-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738866/
https://www.ncbi.nlm.nih.gov/pubmed/29262813
http://dx.doi.org/10.1186/s12882-017-0789-x

Ejemplares similares